This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 11/01/2021
Location: Virtual
Subject: Pfizer-BioNTech COVID-19 Vaccine for Children Aged 5 through 11
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Healthcare professionals, industry, state and local public health organizations, patient advocacy groups, national immunization organizations, and other stakeholders

Event Date: 11/02/2021
Location: Virtual
Subject: Work of the FDA
FDA Participant/Group: N/A
Non FDA Participant/Group: Robert Wood Johnson Foundation Health Policy Fellows, the National Academy of Medicine (NAM) Distinguished Nurse Scholar-in-Residence, and NAM staff

Event Date: 11/03/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeuctic Interventions and Vaccines (ACTIV)

Event Date: 11/05/2021
Location: Virtual
Subject: Updates on OneSource and COVID Trial
FDA Participant/Group: N/A
Non FDA Participant/Group: Laura Esserman (University of California, San Francisco);

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 11/03/2021
Location: Virtual
Subject: China General Administration of Customs and U.S. Food and Drug Administration Annual Bilateral Meeting on the Safety of Food and Feed
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several China General Administration of Customs staff

Event Date: 11/04/2021
Location: Virtual
Subject: FDA and STOP Alliance Food Safety Culture Webinar
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members from the foods industry, academia, and government

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 11/05/2021
Location: Virtual
Subject: Critical Path Institute / FDA Annual Meeting
FDA Participant/Group: MICHELLE CAMPBELL; JEFFREY SIEGEL; JACQUELINE CORRIGAN CURAY; MITRA AHADPOUR; THERESA MULLIN;
Non FDA Participant/Group: Participants from regulatory agencies, industry, and academia

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 11/02/2021
Location: Virtual
Subject: COVID-19 Vaccine Updates on Boosters and Children
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: State health department heads from the Association of State and Territorial Health Officials

Event Date: 11/03/2021
Location: Virtual
Subject: Cell and Gene Therapies; What’s Ahead: In Conversation With Peter Marks
FDA Participant/Group: N/A
Non FDA Participant/Group: Invitees to the FasterCures Virtual Roundtable

Event Date: 11/04/2021
Location: Virtual
Subject: Securing Our Children’s Health: A Virtual Town Hall About Kids and COVID-19
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Black Coalition Against COVID’s Making It Plain: Children Vaccination Town Hall

Event Date: 11/05/2021
Location: Virtual
Subject: Artificial Intelligence / Data Science Needs Specific to Biomanufacturing
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the National Academies of Sciences, Engineering, and Medicine’s Broadening Data Science Education for the Future Biomanufacturing Workforce: A Meeting of Experts

Event Date: 11/06/2021
Location: Virtual
Subject: FDA Regulation of Cellular Products and Derivatives
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Mayo Clinic Symposium on Regenerative Medicine and Surgery

Event Date: 11/06/2021
Location: Virtual
Subject: Vaccination in Young Children: Recap of Recent Decisions and the Data Underlying Them
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Centers for Disease Control and Prevention / Infectious Diseases Society of America COVID-19 Clinician Call

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 11/03/2021
Location: Virtual
Subject: Biotechnology Consultation on Canola Oil Long Chain Polyunsaturated Fatty Acids (LC-PUFA)
FDA Participant/Group: STEVEN MUSSER; FELICIA ELLISON; JASON DIETZ; LESLIE KUX; DAVID EDWARDS; JENNIFER DOOREN; DENNIS KEEFE;
Non FDA Participant/Group: Ali Scott, Aline DeLucia, Carl Andre, Chantelle Donahue, Drew Olson (BASF - Cargill);

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 11/04/2021
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: JEANETTE MURPHY; WILLIAM FLYNN; ANNE NORRIS; DAVID EDWARDS; JENNIFER ERICKSON; TRACEY FORFA; SIOBHAN DELANCEY; TIMOTHY SCHELL; ANTONIA MONIQUE SENNETT;
Non FDA Participant/Group: Representatives from Pet Food Institute (PFI)

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event